KR20080101408A - Composition for aid to stop smoking and its manufacturing method - Google Patents
Composition for aid to stop smoking and its manufacturing method Download PDFInfo
- Publication number
- KR20080101408A KR20080101408A KR1020070048288A KR20070048288A KR20080101408A KR 20080101408 A KR20080101408 A KR 20080101408A KR 1020070048288 A KR1020070048288 A KR 1020070048288A KR 20070048288 A KR20070048288 A KR 20070048288A KR 20080101408 A KR20080101408 A KR 20080101408A
- Authority
- KR
- South Korea
- Prior art keywords
- dried
- weight
- root
- smoking
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 230000000391 smoking effect Effects 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 19
- 230000005586 smoking cessation Effects 0.000 claims abstract description 18
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 9
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 9
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 9
- 229940107131 ginseng root Drugs 0.000 claims description 9
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 241000208422 Rhododendron Species 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 8
- 229960002715 nicotine Drugs 0.000 abstract description 8
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 5
- 235000008434 ginseng Nutrition 0.000 abstract description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract description 2
- 235000021028 berry Nutrition 0.000 abstract description 2
- 239000010268 Acori graminei Rhizoma Substances 0.000 abstract 1
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 206010013754 Drug withdrawal syndrome Diseases 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 description 16
- 239000003814 drug Substances 0.000 description 14
- 241001071795 Gentiana Species 0.000 description 11
- 241000157835 Gardenia Species 0.000 description 10
- 230000002738 anti-smoking effect Effects 0.000 description 10
- 239000013589 supplement Substances 0.000 description 10
- 235000013399 edible fruits Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229940124535 smoking cessation aid Drugs 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 244000061176 Nicotiana tabacum Species 0.000 description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 7
- 235000019504 cigarettes Nutrition 0.000 description 7
- 208000019901 Anxiety disease Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000036506 anxiety Effects 0.000 description 6
- 241000202807 Glycyrrhiza Species 0.000 description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 229940010454 licorice Drugs 0.000 description 5
- 244000265736 Nelumbo pentapetala Species 0.000 description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000009931 harmful effect Effects 0.000 description 4
- 229940124595 oriental medicine Drugs 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 244000299790 Rheum rhabarbarum Species 0.000 description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 description 2
- 240000001851 Artemisia dracunculus Species 0.000 description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 239000001138 artemisia absinthium Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 235000013073 Acorus gramineus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000605447 Anemarrhena Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000577925 Bupleurum komarovianum Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000022540 Consciousness disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012239 Delusion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241001521474 Liriope <hydrozoan> Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241000424774 Plagiorhegma dubium Species 0.000 description 1
- 241001257016 Platyphylla Species 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241001408665 Timandra griseata Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229930191283 anemarrhena Natural products 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 231100000868 delusion Toxicity 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 금연 보조용 조성물 및 그 제조방법에 관한 것으로, 보다 상세하게는 종래 한방에서 약재로 사용되어 안정성이 입증되어 왔던 11가지의 특정 한약재를 선정하고, 상기 선정된 한약재를 복용하기에 적합한 추출물로 제조함으로써, 복용에 의한 부작용이나 해가 거의 없고 흡연에 의한 담배 맛을 저하시키면서 금연에 의한 일시적인 금단현상을 제거할 수 있는 금연 보조용 조성물 및 그 제조방법에 관한 것이다.The present invention relates to a non-smoking auxiliary composition and a method for manufacturing the same, and more specifically, 11 specific herbal medicines, which have been used in traditional medicine as a medicinal herb and whose stability has been proven, and extracts suitable for taking the selected herbal medicines. The present invention relates to a non-smoking supplement composition and a method for manufacturing the same, which have almost no side effects or harm caused by taking and can remove the temporary withdrawal phenomenon due to smoking cessation while lowering the taste of tobacco by smoking.
우리나라에서 담배는 남녀 성인의 기호품으로 많이 애용되고 있는 실정이다.In Korea, cigarettes are a favorite item of male and female adults.
일반적으로 담배에는 니코틴, 타르, 일산화 탄소 등 각종 독성 물질과 20여 가지의 발암 물질이 들어 있는 것으로 알려져 있는데, 이중 일산화 탄소는 혈액의 산소 운반을 방해하고 신진대사에 장애를 주어 조기 노화현상을 일으킬 수 있으며, 니코틴은 말초 혈관을 수축하여 혈압을 높이기 때문에 각성 효과를 제공하기도 하지만 동맥경화증과 소화기계통에 궤양을 유발하고, 특히 중독성을 유발하여 금연을 어렵게 하며, 타르는 폐로 축적되면 체외로 배출되지 않아 각종 폐질환을 일으키는 주요 원인으로 작용하는 것으로 알려져 있다.Generally, cigarettes are known to contain various toxic substances such as nicotine, tar and carbon monoxide and about 20 kinds of carcinogens. Among them, carbon monoxide interferes with oxygen transport of blood and impairs metabolism, causing premature aging. Nicotine may also stimulate the peripheral blood vessels to increase blood pressure, which may provide an arousing effect, but may cause ulcers in atherosclerosis and digestive system, especially intoxication, making it difficult to quit smoking, and when tar accumulates into the lungs, It is known to act as a major cause of various lung diseases.
구체적으로 흡연 폐해에 의한 질환으로는 의학적으로 폐암뿐만 아니라 구강, 후두, 식도, 방광, 신장, 위, 췌장, 그리고 자궁경부 등 많은 암 질환과 심혈관질환 및 만성폐쇄성폐질환 등의 주요 원인으로 보고되고 있다.Specifically, the diseases caused by smoking lungs are medically reported as lung cancers, as well as many cancer diseases such as oral cavity, larynx, esophagus, bladder, kidney, stomach, pancreas, and cervix, as well as cardiovascular diseases and chronic obstructive pulmonary diseases. have.
하지만, 최근에는 청소년을 비롯하여 흡연 연령이 점차 낮아지고 담배로 인한 흡연의 폐해가 많이 알려지기 시작하면서, 담배에 대한 경각심이 고취되어 금연 열풍이 일고 있다. However, in recent years, the age of smoking, including adolescents, gradually decreases and the harmful effects of smoking due to cigarettes are widely known, and the awareness of cigarettes is heightened, resulting in a smoking cessation craze.
그러나, 앞서 설명하였다시피, 니코틴에 의해 담배 중독에 걸린 흡연자들은 금연을 시도한다고 해도 금단현상(禁斷現象)에 의해 중도에 포기하는 사례가 많은 실정이다.However, as described above, smokers who are addicted to tobacco by nicotine are often abandoned due to withdrawal even if they try to quit.
구체적으로 흡연에 의한 금단현상은 흡연자가 담배 속에 있는 니코틴 등에 의해 중독된 후, 흡연을 중단하였을 때, 일어나는 정신, 신체상의 증상을 말하는 것으로, 일반적으로 신체증상으로는 재채기, 가래, 가려움증, 두통, 변비, 설사, 구토 등이 나타나고, 정신상의 증상으로는 불면증, 통증, 불안, 허탈감, 집중력 감소, 환각, 망상, 흡연 욕구 증가 따위의 증상이 나타나는 것으로 알려져 있다.Specifically, the withdrawal phenomenon caused by smoking refers to the mental and physical symptoms that occur when a smoker is addicted to nicotine in a cigarette and then stops smoking. Generally, physical symptoms include sneezing, sputum, itching, headache, Constipation, diarrhea, vomiting and the like, and mental symptoms such as insomnia, pain, anxiety, deprivation, concentration concentration, hallucinations, delusions, smoking desire is known to appear.
이에, 본 발명자는 금연 시, 금단현상 및 흡연 욕구를 완화하고 담배 맛은 오히려 저하시켜서, 궁극적으로 흡연자의 금연을 원활하게 이루어지게 하면서, 독성이나 부작용은 거의 없는 안정한 금연 보조용 조성물을 개발하고자 하였다.Accordingly, the present inventors have attempted to develop a stable smoking cessation composition with little toxicity or side effects while relieving withdrawal and smoking urges and lowering the taste of cigarettes, ultimately making smoking cessation smoothly, when quitting smoking. .
하지만, 인삼, 천문동, 황련, 용담, 치자 열매, 맥문동, 지모근, 감초, 황금, 시호 및 석창포의 혼합 추출물이 본 발명에서 개발하고자 하는 금연 보조용 조 성물로 금단현상을 완화하는데 사용되었다는 문헌이나 자료는 아직 개시된 바가 없다.However, ginseng, astronomical dong, rhubarb, gentian, gardenia fruit, macmundong, jimo-geun, licorice, golden, shiho and Seokchangpo mixed extracts have been used to alleviate the withdrawal phenomenon as a composition for aiding smoking. Data have not been disclosed yet.
본 발명의 목적은 인삼, 천문동, 황련, 용담, 치자 열매, 맥문동, 지모근, 감초, 황금, 시호 및 석창포의 혼합 추출물을 유효성분으로 함유한 금연 보조용 조성물을 제공하는 것이다.An object of the present invention is to provide a non-smoking auxiliary composition containing a mixed extract of ginseng, astronomical dong, rhubarb, gentian, gardenia fruit, mackmundong, jimo-geun, licorice, golden, siho and Seokchangpo as an active ingredient.
또한, 본 발명의 다른 목적은 상기 금연 보조용 조성물의 제조방법을 제공하는 것이다.In addition, another object of the present invention to provide a method for preparing the smoking cessation auxiliary composition.
상기와 같은 목적을 달성하기 위하여, 본 발명은 말린 인삼근 5~8 중량%, 말린 천문동 덩이뿌리 5~8 중량%, 말린 황련근 5~8 중량%, 말린 용담근 5~8 중량%, 말린 치자나무 열매 5~8 중량%, 말린 맥문동 덩이뿌리 5~8 중량%, 말린 지모근 5~8 중량%, 말린 감초근 5~8 중량%, 말린 황금근 8~11 중량%. 말린 시호근 11~14 중량% 및 말린 석창포 16~22 중량%을 혼합한 혼합물의 용매 추출물을 유효성분으로 함유하는 금연 보조용 조성물을 제공한다.In order to achieve the above object, the present invention is dried ginseng root 5 ~ 8% by weight, dried astronomical tuberculosis root roots 5 ~ 8% by weight, dried yellow lotus root 5 ~ 8% by weight, dried gentian root 5 ~ 8% by weight, dried 5-8% by weight of Gardenia fruit, 5-8% by weight of dried wormwood roots, 5-8% by weight of dried hair roots, 5-8% by weight of dried licorice root, 8-11% by weight of dried golden root. Provided is a non-smoking auxiliary composition containing as an active ingredient a solvent extract of a mixture of 11-14% by weight of dried Shiho-geun and 16-22% by weight of dried Seokchang-po.
또한, 다른 목적을 달성하기 위하여, 본 발명은 말린 인삼근 5~8 중량%, 말린 천문동 덩이뿌리 5~8 중량%, 말린 황련근 5~8 중량%, 말린 용담근 5~8 중량%, 말린 치자나무 열매 5~8 중량%, 말린 맥문동 덩이뿌리 5~8 중량%, 말린 지모 근 5~8 중량%, 말린 감초근 5~8 중량%, 말린 황금근 8~11 중량%. 말린 시호근 11~14 중량% 및 말린 석창포근 16~22 중량%을 혼합한 혼합물을 물 또는 알코올의 용매에 넣고 가열하여 추출하는 것을 특징으로 하는 금연 보조용 조성물의 제조방법을 제공한다.In addition, in order to achieve another object, the present invention is dried dried ginseng root 5 ~ 8% by weight, dried astronomical dong dong root 5 ~ 8% by weight, dried yellow lotus root 5 ~ 8% by weight, dried gentian root 5 ~ 8% by weight, dried 5-8% by weight of Gardenia fruit, 5-8% by weight of dried wormwood roots, 5-8% by weight of dried hair roots, 5-8% by weight of dried licorice root, 8-11% by weight of dried golden root. Provided is a method for producing a non-smoking auxiliary composition, characterized in that the mixture is mixed with 11 ~ 14% by weight of dried shiho root and 16 ~ 22% by weight dried rhizome roots in a solvent of water or alcohol.
이하, 본 발명을 상세히 설명하기로 한다.Hereinafter, the present invention will be described in detail.
이때, 여기서 사용되는 기술 용어 및 과학 용어에 있어서 다른 정의가 없다면, 이 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 통상적으로 이해하고 있는 의미를 가진다.At this time, if there is no other definitions in the technical terms and scientific terms used herein, those having ordinary skill in the art to which this invention belongs have the meaning that is commonly understood.
또한, 종래와 동일한 기술적 구성 및 작용에 대한 반복되는 설명은 생략하기로 한다.In addition, repeated description of the same technical configuration and operation as in the prior art will be omitted.
본 발명은 종래 한방에서 약재로 사용되어 안정성이 입증되어 왔던 11가지의 특정 한약재를 선정하고, 상기 선정된 한약재를 복용하기에 적합한 추출물로 제조함으로써, 복용에 의한 부작용이나 해가 거의 없고 흡연에 의한 담배 맛을 저하시키면서 금연에 의한 일시적인 금단현상을 제거할 수 있는 금연 보조용 조성물을 개발한 것이다.The present invention by selecting 11 specific herbal medicines that have been used in traditional medicine as a herbal medicine has been proven to be stable, and manufactured by extracts suitable for taking the selected herbal medicine, there are almost no side effects or harms caused by the use of smoking It has been developed a composition for smoking cessation aids that can remove the temporary withdrawal caused by smoking cessation while lowering the taste of tobacco.
본 발명의 금연 보조용 조성물은 복용하기 간편하면서 거부감을 없애기 위해, 말린 인삼근, 말린 천문동 덩이뿌리, 말린 황련근, 말린 용담근, 말린 치자나무 열매, 말린 맥문동 덩이뿌리, 말린 지모근, 말린 감초근, 말린 황금근. 말린 시호근 및 말린 석창포로 이루어지는 11가지 혼합물을 추출 용매를 사용하여 금연 성분을 추출한 추출물을 사용한다.The composition for smoking cessation aid of the present invention is easy to take, in order to eliminate the rejection, dried ginseng root, dried astronomical dong dong root, dried rhododendron root, dried gentian root, dried gardenia fruit, dried gingko dong tuberculum, dried Jimi root, dried licorice Root, dried golden root. Eleven mixtures consisting of dried Shihogeun and dried Seokchangpo were used as extracts of non-smoking components using an extraction solvent.
이때, 추출 용매로는 물 또는 메탄올이나 에탄올 등의 알코올을 사용하는 것이 바람직하다. 이는 상술한 물과 알코올과 같이 인체에는 무해하거나 해를 최소화할 수 있는 추출 용매를 사용함으로써, 인체에 안정하면서 상기 추출물에서 인체에 유해한 잔존 용매의 추가 제거 공정을 불필요하게 할 수 있기 때문이다.At this time, it is preferable to use water or alcohol such as methanol or ethanol as the extraction solvent. This is because by using an extraction solvent that is harmless to the human body or minimizes harm, such as water and alcohol described above, it is possible to eliminate the additional removal of the residual solvent that is stable to the human body and harmful to the human body in the extract.
하지만, 본 발명에 따른 한약재 추출물은 상술한 추출 용매에 의해 국한되는 것은 아니며, 본 발명의 목적에 부합되는 추출 용매라면 그 어느 것을 사용해도 무방하다.However, the herbal extracts according to the present invention are not limited to the above-described extraction solvents, and any extraction solvents suitable for the purpose of the present invention may be used.
본 발명에서 사용되는 물은 보건부 기준하여 음용 기준에 적합한 물을 말하는 것으로, 일반적으로 여과기나 정수기 등으로 여과시킨 정제수, 멸균수, 음이온수 등의 물이나 수돗물, 생수 등을 사용할 수 있다.The water used in the present invention refers to water suitable for drinking standards based on the Ministry of Health, and generally can be purified water filtered through a filter or water purifier, sterilized water, anion water, tap water, bottled water and the like.
본 발명에서 말린 한약재는 자연상태에서 말리거나 인위적인 건조기에서 말린 한약재를 말하며, 구체적으로 말리는 건조기간 동안 약재의 총중량이 6% 이내로 변동되지 않는 상태로 말린 한약재를 사용하는 것이 바람직하다.The dried herbal medicine in the present invention refers to a herbal medicine dried in a natural state or dried in an artificial dryer, and in particular, it is preferable to use the dried herbal medicine in a state in which the total weight of the medicine does not vary within 6% during the drying period.
본 발명에서 덩이뿌리는 괴근(塊根)이라고도 하며, 뿌리가 양분을 저장하기 위해 뚱뚱해 진 것을 말한다.In the present invention, the tuber root is also known as goose root (塊根), the root is fat to store nutrients.
본 발명에서 추출물의 형태는 액체(液體) 또는 고체(固體)일 수 있으며, 고체일 경우에는 본 발명에 따른 혼합 약재를 용매 추출한 추출액을 열풍 건조, 진공 건조 또는 분무 건조하여 제조한 것을 말한다. 다만, 본 발명의 조성물은 약효의 신속성이나 복용의 편리성 측면에서 액체 상태의 추출물로 복용하는 것이 바람직하다.In the present invention, the extract may be in the form of a liquid or a solid, and in the case of a solid, it refers to one prepared by hot-air drying, vacuum drying or spray drying of the extract extracted solvent mixture of the mixed medicine according to the present invention. However, the composition of the present invention is preferably taken as an extract in a liquid state in terms of speed of drug efficacy or convenience of taking.
본 발명에서 사용되는 11종의 한약재는 한방에서 일반적으로 보약재에 사용되는 약재로서 각각 독성 및 부작용이 없는 약재이고 상기 11종으로 혼합된 약재 사이에는 혼합 사용이 금기시되는 약재들이 없기 때문에, 한방 학계에서는 안정성이 입증된 자명한 사항이라 할 수 있다.The eleven kinds of herbal medicines used in the present invention are medicines that are generally used in herbal medicine as herbal medicines without toxicities and side effects, and there are no herbal medicines which are contraindicated in the mixed medicines of the 11 medicines. In academic circles, the stability is obvious.
이중, 본 발명에서 말린 인삼근(人蔘根)은 학명이 Panax schinseng Nees이고, 한방에서는 강장, 강심(强心), 건위(健胃), 보정, 진정, 자양에 사용한다. 본 발명의 금연 보조 조성물에서는 상술한 효능 이외에 금연으로 인한 불안감과 스트레스 등으로 인하여 쇠해진 기력과 체력을 감초, 황련 및 천문동 등의 약재와 함께 활성화시켜 주는 역할을 한다.Of these, the dried ginseng root (人蔘 根) in the present invention is scientific name Panax It is schinseng Nees, and it is used in tonic, strong heart (强 心), healthy stomach (健,), correction, soothing, and nourishment. In addition to the effects described above, the smoking cessation composition of the present invention serves to activate energy and stamina due to anxiety and stress caused by smoking cessation, along with herbs such as licorice, yellow lotus and astronomical dong.
말린 천문동(天門冬) 덩이뿌리는 학명이 Aspargus lucidus Lindl이고, 한방에서는 진해, 이뇨, 강장제로 이용한다. 본 발명의 금연 보조용 조성물에서는 황금, 치자, 용담 및 맥문동과 함께 이뇨를 촉진하여 소변으로 니코틴 등의 흡연 노폐물을 체내에서 신속히 배출되게 하는 역할을 한다. Aspargus, scientific name sown in dried astronomical tube lucidus Lindl, used in herbal medicine as antitussive, diuretic, tonic. In the smoking cessation composition of the present invention, gold, gardenia, gentian, and pulmonary pulmonary stimulation with diuresis act as a urine to quickly discharge smoking wastes such as nicotine in the body.
말린 황련근(黃連根))는 학명이 Jeffersonia dubia (Maxim)benth, et Hook,f이고, 한방에서는 건위, 진정, 소염에 사용한다. 본 발명의 금연 보조용 조성물에서는 기력 증진뿐만 아니라 석청포, 인삼 등과 함께 금연으로 인한 정신불안, 긴장 등의 금단 증상 및 흡연으로 인한 소화불량을 완화시켜 주는 역할을 한다.Dried yellow lotus root is known as Jeffersonia dubia (Maxim) benth, et Hook, f. For herbal use, it is used for dryness, soothing and anti-inflammatory. The anti-smoking supplement composition of the present invention serves to relieve indigestion due to smoking and withdrawal symptoms such as mental anxiety, tension due to quitting smoking, as well as enhanced energy and quarries.
말린 용담근(龍膽根))은 학명이 Gentiana scabra Beg이고, 한방에서는 건위, 혈압강하 및 이뇨에 이용한다. 본 발명의 금연 보조용 조성물에서는 이뇨 작용으로 체외로 흡연 유해 물질을 신속히 배출되게 하면서, 혈압을 강하하여 긴장감을 해소 해소하는 역할을 한다.Dried gentian root is known as Gentiana It is scabra Beg, and it is used for dry stomach, lowering blood pressure and diuresis in oriental medicine. In the composition for smoking cessation aid of the present invention serves to relieve tension by lowering blood pressure while quickly discharging harmful substances to the body through diuretic action.
말린 치자 열매는 학명이 Gradenia jasminoides Ellis이고 잘 익은 열매를 건조하여 사용하는데, 한방에서는 이뇨, 열독, 갈증해소, 불면증에 사용한다. 본 발명의 금연 보조용 조성물에서는 이뇨 작용으로 인한 흡연 노폐물을 제거하고 불면의 금단현상을 완화해주는 역할을 한다.Dried gardenia fruit is scientific name Gradenia It is jasminoides Ellis, and it is used to dry ripe fruits. In oriental medicine, it is used for diuresis, heat poisoning , thirst quenching and insomnia. The smoking cessation composition of the present invention serves to remove smoking waste due to diuretic action and to alleviate insomnia withdrawal.
말린 맥문동(麥門冬) 덩이뿌리는 학명이 Liriope platyphylla wang et Tang이고, 한방에서는 자양, 강장, 이뇨 및 혈당강하에 사용한다. 본 발명의 금연 보조용 조성물에서는 혈당 강하로 인해 긴장이나 스트레스를 완화하고 니코틴의 유해 물질을 체외로 신속히 배출해 주는 역할을 한다.Dried maekmundong (麥門冬) tuberous root is the scientific name Liriope It is platyphylla wang et Tang, and it is used in Korean medicine for nourishment, tonic, diuresis and hypoglycemic. The anti-smoking supplement composition of the present invention serves to relieve tension or stress due to blood sugar drop and quickly discharge harmful substances of nicotine out of the body.
말린 지모근(知母根)은 학명이 Anemarrhena asphodeloides Bunge이고, 한방에서는 갈증제거, 기침 및 가래 제거에 사용한다. 본 발명의 금연 보조용 조성물에서는 흡연으로 인한 가래를 제거하고 갈증으로 인한 심리적 불안 증세를 낮추어 금단현상을 완화해 주는 역할을 한다.Dried Jimo Geun (知 학 根) Anemarrhena It is a bundle of asphodeloides , and it is used in herbal medicine to quench thirst, cough and sputum. In the anti-smoking supplement composition of the present invention serves to remove sputum caused by smoking and to reduce the psychological anxiety caused by thirst to alleviate the withdrawal phenomenon.
말린 감초근(甘草根)은 학명이 Glycyrrhiza uralensis Fisch이고, 동의보감 등의 한방에서는 오장육부의 한열(寒熱)과 사기(邪氣)를 다스리며 눈, 코, 입 및 귀와 대소변의 생리 현상을 정상이 되게 하고, 모든 혈맥을 소통시키며, 근육과 뼈를 튼튼하게 하고, 영양 상태를 좋게 하면서, 모든 약의 독성을 해독하고, 조합된 한약재 간의 약효를 잘 나타나게 하는데 사용한다. 본 발명의 금연 보조용 조성물에서는 감미(甘味)를 제공하여 복용하기 용이하게 하면서 사용하고 있는 다른 약재 간의 효능이 잘 나타나게 해 주는 역할을 한다.Dried licorice root has the scientific name Glycyrrhiza uralensis Fisch, and oriental medicine such as Dongbobogam controls the heat and fraud of the five intestines, normalizes the physiology of the eyes, nose, mouth, ears and faeces, communicates all blood veins, It is used to strengthen and improve nutrition, to detoxify the toxicity of all medicines, and to show the efficacy of the combined herbs. In the composition for smoking cessation aid of the present invention provides a sweetness (甘味) and serves to make the effect between the other medicines used well while being easy to take.
말린 황금근(黃芩根)은 학명이 Scutellaria baicalensis Georgi이고, 한방에서는 해열, 이뇨, 지사, 이담 및 소염제로 사용한다. 본 발명의 금연 보조용 조성물에서는 이뇨 작용으로 니코틴을 체외로 신속히 배출시키는 역할을 주로 한다.Dried golden root is known as Scutellaria baicalensis Georgi, and is used in herbal medicine as antipyretic, diuretic, branch, itch and anti-inflammatory. In the composition for assisting smoking cessation of the present invention, nicotine is quickly discharged to the outside by the diuretic effect.
말린 시호근(柴胡根)은 학명이 Bupleurum Komarovianum L이고, 한방에서 해열, 진통, 강장제에 이용한다. 본 발명의 금연 보조용 조성물에서는 금단현상으로 나타나는 진통을 완화하고 신진대사를 원활하게 해주는 역할을 한다.Dried Shiho-geun is known as Bupleurum Komarovianum It is L and is used for antipyretic, analgesic, and tonic in one shot. In the composition for smoking cessation aid of the present invention serves to alleviate the pain caused by withdrawal phenomenon and to smooth the metabolism.
말린 석창포(石菖蒲)는 뿌리와 줄기를 사용하고, 학명이 Acorus gramineus Soland이고, 한방에서는 진정, 건위, 진통, 이뇨, 발열, 안면홍조, 의식몽롱상태, 호흡촉박, 의식장애 등에 사용한다. 본 발명의 금연 보조용 조성물에서는 특히 금단현상으로 인한 무기력증 해소나 과도한 스트레스를 진정시키는 역할을 한다.Dried Seokchangpo (石菖蒲) uses roots and stems, scientific name is Acorus gramineus Soland, and in oriental medicine, it is used for soothing, dry stomach, pain relief, diuresis, fever, hot flashes, consciousness dreams, breathing impulse, consciousness disorder. In the smoking cessation composition of the present invention, in particular, serves to relieve lethargy or excessive stress caused by withdrawal phenomenon.
이때, 본 발명에서는 전체 혼합물 100 중량% 기준으로 인삼근 5~8 중량%, 말린 천문동 덩이뿌리 5~8 중량%, 말린 황련근 5~8 중량%, 말린 용담근 5~8 중량%, 말린 치자나무 열매 5~8 중량%, 말린 맥문동 덩이뿌리 5~8 중량%, 말린 지모근 5~8 중량%, 말린 감초근 5~8 중량%, 말린 황금근 8~11 중량%. 말린 시호근 11~14 중량% 및 말린 석창포 16~22 중량%을 혼합한 혼합물을 물에 넣고 추출 용매로 추출하는데, 이는 인삼, 천문동, 황련, 용담, 치자 열매, 맥문동, 지모, 감초의 경우에는 동일한 양으로 최소 5 중량%를 혼합하여 다리고, 황금은 8 중량%, 시호는 11 중량% 및 석창포는 16 중량%를 사용해야 상술한 효능이 충분히 나타나고, 인삼, 천문동, 황련, 용담, 치자 열매, 맥문동, 지모, 감초를 8 중량% 초과하여 사용하거나 황금은 11 중량%, 시호는 14 중량% 및 석창포는 22 중량%를 초과하여 사 용할 경우에는 다른 약재를 충분하게 사용할 수 없기 때문이다.At this time, 5 ~ 8% by weight of ginseng root, 5 ~ 8% by weight of dried Root Root Root, 5-8% by weight of dried Rhododendron, 5-8% by weight of dried gentian root, dried gardenia 5-8% by weight of the berries, 5-8% by weight of dried worms, 5-8% by weight of dried hair roots, 5-8% by weight of dried licorice root, 8-11% by weight of dried golden root. A mixture of 11-14% by weight of dried Siho-geun and 16-22% by weight of dried Seokchang-po is placed in water and extracted with extraction solvent.In case of ginseng, cheonmun-dong, rhubarb, gentian, gardenia fruit, macmundong, jimo, licorice In the same amount, at least 5% by weight of the mixture, gold, 8% by weight, Siho 11% by weight and Seokchangpo should use 16% by weight to fully exhibit the above-mentioned efficacy, ginseng, cheonmundong, hwangyeon, gentian, gardenia fruit, If more than 8% by weight of ganmundong, gimo, licorice, or 11% by weight of gold, 14% by weight of sea tiger and 22% by weight of stone spear is not used enough other medicines.
그리고, 상술한 본 발명의 금연 보조용 조성물에 복용하기 편리하고 안정성을 개선하기 위해, 식품이나 약제학적으로 허용된 감미제(甘味劑), 향미제(香味劑), 부형제(賦形劑) 및 방부제(防腐劑) 등을 더 첨가하여 사용하는 것이 바람직하다. In addition, food and pharmaceutically acceptable sweeteners, flavoring agents, excipients and preservatives in order to improve the stability and convenience to take in the anti-smoking supplement composition of the present invention described above. It is preferable to add (iv) and the like further.
구체적으로 상기 부형제의 경우에는 염수, 완충제, 덱스트로스, 물, 글리세롤, 링거액, 락토즈, 수크로즈, 칼슘 실리케이트, 메틸 셀룰로오즈 또는 에탄올을 담체를 사용하여 분말, 과립, 주사액, 시럽, 용액제, 정제, 좌약 등과 같은 의약(medicine) 제형으로 제조할 수 있다. 그리고, 상기 제형에 충진제, 항응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 포함하여 포유동물에 투여된 후 활성성분의 신속, 지속 또는 지연된 방출을 제공할 수 있도록 제형화할 수 있다.Specifically, in the case of the excipient, saline, buffer, dextrose, water, glycerol, Ringer's solution, lactose, sucrose, calcium silicate, methyl cellulose or ethanol using a carrier powder, granules, injection solution, syrup, solution, tablet It may be prepared in a pharmaceutical formulation such as suppositories. In addition, the formulation may further include fillers, anti-coagulants, lubricants, wetting agents, flavors, emulsifiers, preservatives, and the like, and may be formulated to provide rapid, sustained or delayed release of the active ingredient after administration to a mammal.
이하, 본 발명의 금연 보조용 조성물을 제조하는 바람직한 공정은 다음과 같다.Hereinafter, a preferred process for producing a composition for smoking cessation aid of the present invention is as follows.
(1) 추출 공정(1) extraction process
말린 인삼근 5~8 중량%, 말린 천문동 덩이뿌리 5~8 중량%, 말린 황련근 5~8 중량%, 말린 용담근 5~8 중량%, 말린 치자나무 열매 5~8 중량%, 말린 맥문동 덩이뿌리 5~8 중량%, 말린 지모근 5~8 중량%, 말린 감초근 5~8 중량%, 말린 황금근 8~11 중량%. 말린 시호근 11~14 중량% 및 말린 석창포 16~22 중량%을 혼합한 혼합물을 물 또는 알코올의 추출 용매에 넣고 가열하여 추출한다. Dried Ginseng Root 5-8% by weight, Dried Astronomical Root Root 5-8% by weight, Dried Rhododendron Root 5-8% by weight, Dried Yongdam-Geun 5-8% by weight, Dried Gardenia Fruit 5-8% by weight, Dried Macmundong Tube 5-8% by weight of root, 5-8% by weight of dried hair root, 5-8% by weight of dried licorice root, 8-11% by weight of dried golden root. A mixture of 11-14% by weight of dried Siho root and 16-22% by weight of dried Seokchang-po is placed in an extraction solvent of water or alcohol and extracted by heating.
이때, 본 발명에서는 상기 약재 혼합물 1g을 추출 용매 20~40㎖에 넣고 가열하는 것이 바람직하다. 이는 20㎖ 미만으로 추출하면 가열하면서 용매가 감소되어 충분히 오랜 시간 동안 다릴 수가 없고, 40㎖를 초과하면 유효성분의 농도가 낮아지기 때문이다. 하지만, 본 발명에서는 상술한 사용 범위 내로 국한되는 것은 아니며, 복용자의 취향에 따라 유효 성분의 농도를 조절하여 약재 혼합물과 추출 용매의 사용 범위를 조절할 수 있다.At this time, in the present invention, it is preferable to put 1 g of the medicinal herb mixture in 20 to 40 ml of the extraction solvent and heat it. This is because if the extraction amount is less than 20 ml, the solvent is reduced while heating, so that it cannot be handled for a sufficiently long time, and if the concentration exceeds 40 ml, the concentration of the active ingredient is lowered. However, the present invention is not limited to the above-mentioned range of use, and the use range of the medicinal mixture and the extraction solvent can be adjusted by adjusting the concentration of the active ingredient according to the taste of the ingestor.
또한, 본 발명에서는 추출 용매가 물인 경우, 온도가 약 20~25℃의 물에 약재 혼합물을 1~2 시간 정도 담가놓은 다음, 가열하여 물이 끓으면 가열 수단(가스불, 전열기 등)의 온도를 낮추고 처음 첨가했던 물의 양이 약 40%까지 줄어들 때까지 서서히 다리는 것이 바람직하다. 구체적으로는 약 5시간 이상을 다리는 것이 바람직하다. 이는 지속적인 높은 온도 조건에서 파괴되기 쉬운 추출 유효 성분의 손실을 가급적이면 억제할 수 있기 때문이다.In addition, in the present invention, when the extraction solvent is water, the temperature of the heating means (gas fire, heater, etc.) is soaked by immersing the medicine mixture in water of about 20 to 25 ℃ for 1 to 2 hours, and then heated to boil water It is advisable to lower the temperature and slowly squeeze until the amount of water initially added is reduced by about 40%. Specifically, it is preferable to bridge about 5 hours or more. This is because the loss of the extraction active ingredient, which is susceptible to destruction under continuous high temperature conditions, can be suppressed if possible.
(2) 정제 공정(2) refining process
상기 제 1공정에서 추출된 액체 추출물은 거름망이나 여과기를 통해 고형분을 제거한다.The liquid extract extracted in the first step removes solids through a strainer or a filter.
또한, 본 발명에서는 상기 여과된 여액을 그냥 복용할 수 있지만, 건조시켜서 분말로 복용할 수 있다.In addition, in the present invention, the filtered filtrate may be just taken, but may be dried and taken as a powder.
한편, 본 발명의 금연 보조용 조성물은 복용자의 취향이나 습관에 따라 복용량에는 한정을 두지는 않으나, 통상적으로 1회, 성인 기준으로 추출물 원액 140~150㎖(일반컵의 약 2/3컵)을 아침 및 점심 식사 후 2시간, 취침 전 30~40분에 부 담을 느끼지 않는 범위 내에서 연속 또는 간헐적으로 복용하는 것이 바람직하다.On the other hand, the anti-smoking supplement composition of the present invention is not limited to the dosage depending on the taste or habit of the user, but usually once, extract adult extract 140 ~ 150ml (about 2/3 cup of the normal cup) on an adult basis It is recommended to take it continuously or intermittently within 2 hours after breakfast and lunch and 30-40 minutes before bedtime.
이하, 본 발명을 구체적인 실시예에 의해 보다 더 상세히 설명하고자 한다. 하지만, 본 발명은 하기 실시예에 의해 한정되는 것은 아니며, 본 발명의 사상과 범위 내에서 여러 가지 변형 또는 수정할 수 있음은 이 분야에서 당업자에게 명백한 것이다.Hereinafter, the present invention will be described in more detail with reference to specific examples. However, the present invention is not limited to the following examples, and it will be apparent to those skilled in the art that various changes or modifications can be made within the spirit and scope of the present invention.
[[ 실시예Example ] 본 발명의 금연 보조용 조성물의 제조] Preparation of Anti-Smoking Auxiliary Composition of the Invention
말린 인삼근 5~8 중량%, 말린 천문동 덩이뿌리 5~8 중량%, 말린 황련근 5~8 중량%, 말린 용담근 5~8 중량%, 말린 치자나무 열매 5~8 중량%, 말린 맥문동 덩이뿌리 5~8 중량%, 말린 지모근 5~8 중량%, 말린 감초근 5~8 중량%, 말린 황금근 8~11 중량%. 말린 시호근 11~14 중량% 및 말린 석창포근 16~22 중량%을 혼합한 혼합물 100g을 22℃ 전후의 물 3ℓ(3,000㎖)에 1시간 동안 담그고, 이를 가스 레인지에서 가열하여 끓인 다음, 바로 불을 줄인 상태에서 5시간 동안 다렸다.Dried Ginseng Root 5-8% by weight, Dried Astronomical Root Root 5-8% by weight, Dried Rhododendron Root 5-8% by weight, Dried Yongdam-Geun 5-8% by weight, Dried Gardenia Fruit 5-8% by weight, Dried Macmundong Tube 5-8% by weight of root, 5-8% by weight of dried hair root, 5-8% by weight of dried licorice root, 8-11% by weight of dried golden root. 100 g of a mixture of 11-14% by weight of dried Siho root and 16-22% by weight of dried Seokgu root was immersed in 3 liters (3,000 ml) of water before and after 22 ° C for 1 hour, heated in a gas cooker and boiled immediately. It was injured for 5 hours with reduced.
상기 다린 추출물 1.2ℓ를 거름망에 통과시켜서, 본 발명의 금연 보조용 조성물(추출 여액)을 제조하였다.1.2 liter of the Darin extract was passed through a strainer to prepare an anti-smoking auxiliary composition (extract filtrate) of the present invention.
[[ 비교예Comparative example 1] One]
본 비교예는 K사의 쌍화차를 상업적으로 구입하여 사용하였다.In this comparative example, K Company's Ssanghwa tea was purchased commercially and used.
[[ 실험예Experimental Example 1] 기호도 검사 1] Preference check
본 실험예에서는 본 발명에 따라 제조된 금연 보조용 조성물의 복용성을 측정하기 위하여, 색, 향, 맛 및 종합적인 기호도를 50인의 관능검사 지원자(남 28명, 여 22명)로 하여금 5점 척도법으로 측정하여 비교/분석하였다(장건형, 식품의 기호성 관능검사, 개문사, 1975).In this Experimental Example, 50, sensory test applicants (28 males, 22 females) were given five points for color, aroma, taste, and overall acceptability in order to measure the dose of the smoking cessation composition prepared according to the present invention. It was measured by the scale method and compared / analyzed (Chang, Kun-Sung, Palatability of Food, Gaemunsa, 1975).
이의 결과, 하기 표 1에 나타난 바와 같이, 종합적인 기호도에 있어서 본 발명의 금연 보조용 조성물은 비교예(종래 한방 음료)와 같이 복용이 간편함을 알 수 있었다. As a result, as shown in Table 1, it was found that the composition for smoking cessation aid of the present invention in a general preference diagram is easy to take as in the comparative example (traditional herbal drink).
[[ 실험예Experimental Example 2] 효능 검사 2] efficacy test
1. 흡연 욕구와 금단현상의 완화 효과1. Ease of craving for smoking and withdrawal phenomenon
본 실험예에서는 금연 경력이 있었던 흡연자 30명(남자 30명)에게 금연을 하게 한 다음, 하루에 취침 전 30 분과, 아침 식사 2시간 후, 점심 식사 2시간 후에 본 발명에 따른 금연 보조용 조성물을 150㎖씩 1주일간 복용시켰다.In the present experimental example, 30 smokers (30 males) who had a history of quitting smoking were allowed to quit smoking, and then 30 minutes before bedtime, 2 hours after breakfast, and 2 hours after lunch, the composition for assisting smoking according to the present invention was prepared. 150 ml each was taken for 1 week.
그런 다음, 설문을 통해 금단현상에 대한 복용자의 느낌을 관능 검사로 상기 실험예1과 같이 측정하였다. Then, the feeling of the taking of the withdrawal phenomenon through the questionnaire was measured by the sensory test as in Experimental Example 1.
설문 항목은 흡연 욕구가 있었는지의 여부와 불안, 긴장 등의 심리적인 스트레스가 있었는지의 여부로 하였다. 이때, 대조구는 실험에 동참한 동일인에 한하여 본 실험 전 금연했었던 경험을 설문에 응답하게 하였다.The questionnaire items were whether there was a desire for smoking and whether there were psychological stresses such as anxiety and tension. At this time, the control group responded to the questionnaire about the experience of quitting smoking before the experiment only for the same person who participated in the experiment.
이의 결과, 하기 표 2에 나타난 바와 같이, 본 발명의 금연 보조용 조성물은 는 전에 금연을 했었던 경우보다 흡연 욕구와 불안이나 긴장 등의 금단현상의 완화하는 데 상당한 효과가 있었음을 알 수 있었다. 이때, 표 2는 설문 응답자의 점수를 모두 합한 후, 이의 평균치를 나타낸 것이다. 하기 데이터와 더불어 또한 본 발명의 조성물을 하루 동안 복용하여도 흡연욕구가 현저히 저하되는 효과를 얻을 수 있었다. As a result, as shown in Table 2, it can be seen that the anti-smoking supplement composition of the present invention had a significant effect in alleviating the withdrawal phenomenon such as smoking desire and anxiety or tension than when the previous quit. At this time, Table 2 shows the average value of the sum of the scores of the survey respondents. In addition to the following data, even when taking the composition of the present invention for one day it was possible to obtain the effect of significantly lowering the smoking desire.
5점: 매우 크다, 4점: 크다, 3점: 보통, 2점: 적다, 1점: 매우 적다.5 points: very large, 4 points: large, 3 points: normal, 2 points: small, 1 point: very small
2. 담배 맛 효과2. tobacco flavor effect
본 실험예에서는 흡연자 30명(남자 30명)에게 금연을 하게 한 다음, 하루에 취침 전 30 분과, 아침 식사 2시간 후, 점심 식사 2시간 후에 본 발명에 따른 금연 보조용 조성물을 150㎖씩 3일간 복용시켰다.In the present experimental example, 30 smokers (30 males) were allowed to quit smoking, and then 30 minutes before bedtime, 2 hours after breakfast, and 2 hours after lunch, 150 ml of the non-smoking supplement composition according to the present invention. Taken daily.
그런 다음, 동일인에 한에서 담배를 다시 피게 한 다음, 평상 시 펴오던 담배 맛과 비교하여 복용 전과 비교하여 설문에 응답하도록 하였다. Then, the same person was allowed to smoke again, and then they were asked to answer the questionnaire compared to their usual taste of cigarettes.
이의 결과, 하기 표 3에 나타난 바와 같이, 본 발명의 금연 보조용 조성물은 담배맛을 현저히 낮추는 것을 입증할 수 있었다. As a result, as shown in Table 3 below, the composition for smoking cessation aid of the present invention was able to prove to significantly lower the taste of tobacco.
상술한 결과로부터, 본 발명에 따른 금연 보조용 조성물은 담배맛을 저감하고 금연으로 인한 금단현상과 흡연 욕구를 완화시킴으로써, 금연 보조제로서 충분한 역할을 할 수 있을 것으로 판단된다.From the above results, it is determined that the anti-smoking supplement composition according to the present invention can play a sufficient role as a smoking cessation aid by reducing tobacco taste and alleviating withdrawal phenomenon and smoking desire due to smoking cessation.
앞에서 설명한 바와 같이, 본 발명의 실시예에 따른 금연 보조용 조성물은 복용에 의한 부작용이나 해가 거의 없고 흡연에 의한 담배 맛을 저하시키면서 금연에 의한 일시적인 금단현상을 제거할 수 있는 효과를 제공한다.As described above, the anti-smoking supplement composition according to the embodiment of the present invention provides an effect of eliminating temporary withdrawal phenomena due to smoking cessation while reducing the taste of tobacco due to no side effects or harm caused by taking.
또한, 본 발명의 금연 보조용 조성물은 종래 보약재로 사용되는 한약재로 이루어져 있어 건강 증진에도 도움을 제공한다.In addition, the non-smoking auxiliary composition of the present invention is made up of herbal medicines used as conventional medicines to provide health benefits.
하지만, 상술한 개시는 일정 범위의 수정, 변화 및 치환이 가능하며, 어떤 경우에는 본 발명의 특징 중 일부만이 사용될 수도 있다. 따라서, 첨부된 청구항들은 본 발명의 사상과 범위에 부합되게 넓게 해석되어야 한다.However, the above disclosure is capable of a range of modifications, changes and substitutions, and in some cases only some of the features of the invention may be used. Accordingly, the appended claims should be construed broadly in accordance with the spirit and scope of the invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070048288A KR100873349B1 (en) | 2007-05-17 | 2007-05-17 | Composition for aid to stop smoking and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070048288A KR100873349B1 (en) | 2007-05-17 | 2007-05-17 | Composition for aid to stop smoking and its manufacturing method |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080101408A true KR20080101408A (en) | 2008-11-21 |
KR100873349B1 KR100873349B1 (en) | 2008-12-10 |
Family
ID=40287674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070048288A KR100873349B1 (en) | 2007-05-17 | 2007-05-17 | Composition for aid to stop smoking and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100873349B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100407A (en) * | 2010-09-15 | 2011-06-22 | 张锐 | Cigarette filtering agent for reducing tar, relieving cough and refreshing |
CN102100406A (en) * | 2010-09-15 | 2011-06-22 | 张锐 | Cigarette filtering agent for smoothing throat, protecting health and refreshing |
KR20180130067A (en) * | 2017-05-26 | 2018-12-06 | 신동진 | Portable Vaporizing And Inhaling Device with Thermal Sterilization |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100274825B1 (en) * | 1997-06-03 | 2000-12-15 | 배오성 | Smoking material having a prohibition function of smoking |
KR20010001582A (en) * | 1999-06-07 | 2001-01-05 | 안철희 | Method for manufacturing a medicine for nonsmoking using a chinese medicine |
KR20030000373A (en) * | 2001-06-23 | 2003-01-06 | 한성신약(주) | Stop smoking |
KR100553643B1 (en) * | 2002-11-27 | 2006-02-22 | 이호재 | The mixtures for nicotine elimination and their manufacturing method |
-
2007
- 2007-05-17 KR KR1020070048288A patent/KR100873349B1/en not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100407A (en) * | 2010-09-15 | 2011-06-22 | 张锐 | Cigarette filtering agent for reducing tar, relieving cough and refreshing |
CN102100406A (en) * | 2010-09-15 | 2011-06-22 | 张锐 | Cigarette filtering agent for smoothing throat, protecting health and refreshing |
CN102100406B (en) * | 2010-09-15 | 2013-02-06 | 张锐 | Cigarette filtering agent for smoothing throat, protecting health and refreshing |
CN102100407B (en) * | 2010-09-15 | 2013-02-06 | 张锐 | Cigarette filtering agent for reducing tar, relieving cough and refreshing |
KR20180130067A (en) * | 2017-05-26 | 2018-12-06 | 신동진 | Portable Vaporizing And Inhaling Device with Thermal Sterilization |
Also Published As
Publication number | Publication date |
---|---|
KR100873349B1 (en) | 2008-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20180037693A (en) | A food composition for preventing and improving lung diseases | |
CN102613705A (en) | Cigarette filter tip with health care function | |
CN103223111B (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method thereof | |
CN106359720A (en) | Health protection tea for clearing heat from throat and moistening lung and preparation method thereof | |
CN108277138A (en) | A kind of health-care and nutritious wine and preparation method thereof | |
CN103055014B (en) | Folium ginkgo health product for preventing senile dementia and preparation method thereof | |
CN104547515A (en) | Tangerine pear syrup and preparation method thereof | |
KR100873349B1 (en) | Composition for aid to stop smoking and its manufacturing method | |
CN104771725B (en) | A kind of drug for treating cold of insufficiency type patients with type Ⅰ DM | |
KR101117669B1 (en) | Nicotine removal material from smoker's body included ginseng | |
CN103041070B (en) | Lipid-lowering and pressure-releasing folium ginkgo health-care product and preparation method thereof | |
CN103977127B (en) | A kind of Chinese medicine composition for the treatment of infantile asthma and preparation method thereof | |
CN101601491B (en) | Chinese medicinal beverage for dispelling summer-heat and damp, eliminating vexation and allaying thirst | |
CN107970368A (en) | A kind of houttuynia oral administration liquid for helping to give up smoking and preparation method thereof | |
CN107897441A (en) | A kind of alleviation smoking causes Gynura procumbens (Lour.) Merr tea of cough and preparation method thereof | |
CN107982510A (en) | A kind of coltsfoot frondosa oral liquid for helping to give up smoking and preparation method thereof | |
CN103417886A (en) | Traditional Chinese medicine composition for treating bronchial asthma and preparing method thereof | |
CN104352589B (en) | A kind of Traditional Chinese medicine smoking stopping liquid with Radix Ginseng as primary raw material and preparation method thereof | |
CN106511892A (en) | Traditional Chinese medicine compound for drug addiction treatment | |
WO2015149391A1 (en) | Preparation of traditional chinese medicine for treating chronic enteritis and preparation method therefor | |
WO2015149395A1 (en) | Preparation of traditional chinese medicine for treating chronic gastritis and preparation method therefor | |
CN109170052A (en) | A kind of dendrobium nobile stomach-nourishing health tea and preparation method thereof | |
CN108968135A (en) | Cigarette removes cigarette poison additive | |
CN111670977B (en) | Qi-regulating spleen-strengthening health-care tea | |
CN109106842B (en) | A medicine for stopping smoking and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121204 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130923 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20141216 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160420 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |